Update on Psilocybin and MDMA scheduling
Published
Related content
- Change to classification of psilocybin and MDMA to enable prescribing by authorised psychiatristsFrom 1 July this year, medicines containing the psychedelic substances psilocybin and MDMA can be prescribed by specifically authorised psychiatrists for the treatment of certain mental health conditions.
- Proposal for the re-scheduling of Codeine productsThe Therapeutic Goods Administration has published an interim decision on a proposal to up-schedule codeine
- Update on nicotine scheduling and proposed restriction on importation of nicotine for use in e-cigarettesPending the final outcome of the process required by law, it has been decided to defer the proposed restriction on importation of personal nicotine vaporisers and, separately, nicotine for use in e-cigarettes